Synthetic RNA drug reverses heart failure with preserved ejection fraction.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
1
4
6
545
DNA methylation distinguishes heart failure with and without reduced ejection fraction.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
3
8
606
The 12th Hatter symposium reports progress in cardio- and neuroprotection.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
2
342
Cardiac and tumor metabolism with checkpoint inhibition.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
1
127
Preclinical models for cardio-oncology research.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
3
200
Does ventricular fibrillation reduce infarct size in patients?
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
1
189
T-cell mediated myocarditis in mice
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
1
122
Immune checkpoint inhibitor mediated cardiotoxicity - age, sex, obesity
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
3
278
Single cell transcriptomics of human endothelial cells.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
7
616
Larger infarction from chronic kidney disease.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
2
6
565
A multi-center trial approach for the study of cardioprotection in pigs has IMPACT.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
1
147
Oxidative stress in heart failure by kidney injury.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
4
230
Macrophages and cardiomyocyte sodium channels in mice.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
1
2
302
Cardio-oncology – chances and challenges
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
1
3
236
AI for infarct size quantification.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
1
1
131
Cardiac cachexia with cancer
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
1
137
Molecular fibroblast activation patterns in heart failure.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
6
17
1,011
Cardioprotection from anthracycline cardiotoxicity.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
4
203
Immunotherapy-related cardiotoxicity.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
1
1
692
Exercise-induced cardioprotection against breast cancer through STAT3 activation.
link.springer.com/article/10.100…
link.springer.com/article/10.100…
0
0
0
121




















